SEC Form D · Amendment · filed October 16, 2020
Novita Pharmaceuticals, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (17)
Daniel Sparks · Stamford, CTExecJonathan J. Zhu · New york, NYDirectorChristy Y. Shue · New York, NYExec · DirectorPassco Parker Manager, LLC · Irvine, CADirectorJonathan J. Zhu · New york, NYDirectorKevin Gasvoda · Stamford, CTDirectorRichard O. Fortmann · San Francisco, CADirectorElliot S. Favus · Mt. Pleasant, SCExec · DirectorTony W. Bartsh · Mt. Pleasant, SCDirectorStephen D. Schroeder · San Francisco, CAExec · DirectorJustin Mahoney · Stamford, CTExec · DirectorChenjian J. Li · New York, NYDirectorXin-Yun Y. Huang · New York, NYDirectorSacks Ventures GP I, LLC · SAN FRANCISCO, CAExec · DirectorJue J. Zhang · New York, NYExec · DirectorPassco Parker Depositor, LLC · Irvine, CAExecDavid J. Moy · New York, NYExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗